Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients.

Slides:

Advertisements

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages

Advertisements

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey Bartolome R. Celli, MD, R.J. Halbert, MD,

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,

Quantification of emphysema with preoperative computed tomography has stronger association with pulmonary complications than pulmonary function test results.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Lung Volume Reduction Reoperations

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease Yasuo Sekine, MD, Takekazu.

Vibration response imaging versus perfusion scan in lung cancer surgery evaluation Nuria Marina, MD, Gema Rodriguez-Trigo, MD, Unai Jimenez, MD, Beatriz.

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months Arturo Navarro-Martin, MD, Samantha Aso, MD, Jon Cacicedo,

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Right lower lobectomy after right upper lobectomy for multiple metastases in lung cancer of the right lower lobe: Benefit of middle lobe preservation

Electronic Updates for JTO Readers

Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography Takeshi.

Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non– Small-Cell Lung Cancer Damien Urban, MBBS, B Med Sc, Jair Bar, MD, PhD,

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer Peter Goldstraw, MB, FRCS, John J. Crowley, PhD

Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD

Frank Detterbeck, MD Journal of Thoracic Oncology

Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP

Therapeutic Bronchoscopy Interventions Before Surgical Resection of Lung Cancer Prashant N. Chhajed, MD, Ralf Eberhardt, MD, Hendrik Dienemann, MD, Andrea.

Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients Jie Dai, PhD,

Systemic and regional pulmonary function after segmentectomy

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

An Updated Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated.

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Management of Intersegmental Plane on Pulmonary Segmentectomy Concerning Postoperative Complications Hajime Saito, MD, PhD, Hayato Konno, MD, PhD, Maiko.

Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma Servet Bölükbas, MD,

Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases Bo Deng, MD, PhD, Stephen D. Cassivi, MD, Mariza.

Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.

Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,

Mirror Mirror on the Wall, Who Is the Fairest of Them All

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer Hiroaki Nomori, MD, Atsushi Shiraishi, MD, Yue Cong, MD,

Catheter Drainage Followed by the Instillation of Bleomycin to Manage Malignant Pericardial Effusion in Non-small Cell Lung Cancer: A Multi-Institutional.

Forced Expiratory Volume in One Second as a Prognostic Factor in Advanced Non- small Cell Lung Cancer Jin Hwa Lee, MD, PhD, Eun Mi Song, MD, Yun Su Sim,

Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey Daniel Morgensztern, MD, Shean Huey Ng,

Immune-Modulating Vaccines in Non-small Cell Lung Cancer

A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative.

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

Ribavirin in Desquamative Interstitial Pneumonia

Ethnic Differences in the Management of Lung Cancer in New Zealand

Compensation of pulmonary function after upper lobectomy versus lower lobectomy Kazuhiro Ueda, MD, Toshiki Tanaka, MD, Masataro Hayashi, MD, Tao-Sheng.

International Thymic Malignancies Interest Group: A Way Forward

European Lung Cancer Conference (ELCC) 2016 Organisation

Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods Alessandro Brunelli,

Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict.

Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD, Charles E.

IASLC 6th Latin American Conference on Lung Cancer

Oral contraceptives improve lung mechanics

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung Cancer Joon Suk Park, MD, Hee Chul Yang, MD, Hong Kwan Kim, MD,

A Review of First-Line Treatment for Small-cell Lung Cancer

Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD

Mark A. Socinski, MD Journal of Thoracic Oncology

Elevated Preoperative C-reactive Protein Predicts Poor Cancer Specific Survival in Patients Undergoing Resection for Non-small Cell Lung Cancer Caroline.

Robert Comis, MD, The Passing of a “Lung Man”

Presentation transcript:

Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients with Emphysema Kosuke Kashiwabara, MD, Ji-Ichiro Sasaki, MD, Tsuyoshi Mori, MD, Hiroaki Nomori, MD, Kazuhiko Fujii, MD, Hirotsugu Kohrogi, MD Journal of Thoracic Oncology Volume 4, Issue 9, Pages 1111-1116 (September 2009) DOI: 10.1097/JTO.0b013e3181ae59e2 Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Postoperative change of the FVC and the FEV1 between the lobectomy group and the segmentectomy group in patients with stage I non-small cell lung cancer with the normal spirometric values. FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; °FVC, postoperative change of the FVC; °FEV1, postoperative change of the FEV1. Journal of Thoracic Oncology 2009 4, 1111-1116DOI: (10.1097/JTO.0b013e3181ae59e2) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Postoperative change of the FVC and the FEV1 between the lobectomy group and the segmentectomy group in patients with stage I non-small lung cancer with the airflow limitations (the FEV1% <70%). FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; °FVC, postoperative change of the FVC; °FEV1, postoperative change of the FEV1. Journal of Thoracic Oncology 2009 4, 1111-1116DOI: (10.1097/JTO.0b013e3181ae59e2) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Correlation between the postoperative change of the FEV1 and the %ppoFEV1. Analysis of a linear correlation was performed with the Pearson’s correlation coefficient test. FEV1, forced expiratory volume in 1 second; %ppoFEV1, ratio of the estimated postoperative FEV1 to the predicted normal value of FEV1. Journal of Thoracic Oncology 2009 4, 1111-1116DOI: (10.1097/JTO.0b013e3181ae59e2) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions